Special communication| Volume 91, ISSUE 11, P1667-1672, November 2010

Common Data Elements for Traumatic Brain Injury: Recommendations From the Biospecimens and Biomarkers Working Group


      Manley GT, Diaz-Arrastia R, Brophy M, Engel D, Goodman C, Gwinn K, Veenstra TD, Ling G, Ottens AK, Tortella F, Hayes RL. Common data elements for traumatic brain injury: recommendations from the Biospecimens and Biomarkers Working Group.
      Recent advances in genomics, proteomics, and biotechnology have provided unprecedented opportunities for translational research and personalized medicine. Human biospecimens and biofluids represent an important resource from which molecular data can be generated to detect and classify injury and to identify molecular mechanisms and therapeutic targets. To date, there has been considerable variability in biospecimen and biofluid collection, storage, and processing in traumatic brain injury (TBI) studies. To realize the full potential of this important resource, standardization and adoption of best practice guidelines are required to insure the quality and consistency of these specimens. The aim of the Biospecimens and Biomarkers Working Group was to provide recommendations for core data elements for TBI research and develop best practice guidelines to standardize the quality and accessibility of these specimens. Consensus recommendations were developed through interactions with focus groups and input from stakeholders participating in the interagency workshop on Standardization of Data Collection in TBI and Psychological Health held in Washington, DC, in March 2009. With the adoption of these standards and best practices, future investigators will be able to obtain data across multiple studies with reduced costs and effort and accelerate the progress of genomic, proteomic, and metabolomic research in TBI.

      Key Words

      List of Abbreviations:

      APOE-e4 (apolipoprotein E4), CDE (common data element), COMT (catechol O-methyltransferase), DNA (deoxyribonucleic acid), EDTA (ethylenediaminetetraacetic acid), EVD (external ventricular drain), LP (lumbar puncture), PBMC (peripheral blood mononuclear cell), RBC (red blood cell), TBI (traumatic brain injury)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Archives of Physical Medicine and Rehabilitation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Teasdale G.M.
        • Nicoll J.A.R.
        • Murray G.
        • Fiddes M.
        Association of apolipoprotein E polymorphism with outcome after head injury.
        Lancet. 1997; 350: 1069-1071
        • Friedman G.
        • Froom P.
        • Sazbon L.
        • et al.
        Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury.
        Neurology. 1999; 52: 244-248
        • Zhou W.
        • Xu D.
        • Peng X.
        • Zhang Q.
        • Jai J.
        • Crutcher K.A.
        Meta-analysis of APOE4 allele and outcome after traumatic brain injury.
        J Neurotrauma. 2008; 25: 279-290
        • Isoniemi H.
        • Tonovuo O.
        • Portin R.
        • Himanan L.
        • Kairisto V.
        Outcome of traumatic brain injury after three decades—relationship to ApoE genotype.
        J Neurotrauma. 2006; 23: 1600-1609
        • Hadjigeorgiou G.M.
        • Paterakis K.
        • Dardiotis E.
        • et al.
        IL-1RN and IL-1B gene polymorphisms and cerebral hemorrhagic events after traumatic brain injury.
        Neurology. 2005; 65: 1077-1082
        • Diaz-Arrastia R.
        • Baxter V.K.
        Genetic factors in outcome after traumatic brain injury: what the Human Genome Project can teach us about brain trauma.
        J Head Trauma Rehabil. 2006; 21: 361-374
        • Prieto D.A.
        • Ye X.
        • Veenstra T.D.
        Proteomic analysis of traumatic brain injury: the search for biomarkers.
        Expert Rev Proteomics. 2008; 5: 283-291
        • Ottens A.K.
        • Kobeissy F.H.
        • Fuller B.F.
        • et al.
        Novel neuroproteomic approaches to studying traumatic brain injury.
        Prog Brain Res. 2007; 161: 401-418
        • Egan M.F.
        • Goldberg T.E.
        • Kolachana B.S.
        • Callicot J.H.
        • Mazzanti C.M.
        • Straub R.E.
        Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia.
        Proc Natl Acad Sci U S A. 2001; 98: 6917-6922
        • De Frias C.M.
        • Annerbrink K.
        • Westberg L.
        • Eriksson E.
        • Adolfsson R.
        • Nilsson L.
        Cotechol O-methyltransferase Val158Met polymorphism is associated with cognitive performance in nondemented adults.
        J Cogn Neurosci. 2005; 17: 1018-1025
        • Lipsky R.H.
        • Sparling M.B.
        • Ryan L.M.
        • et al.
        Association of COMT Val158Met genotype with executive functioning following traumatic brain injury.
        J Neuropsychiatry Clin Neurosci. 2005; 17: 465-471
        • Xie P.
        • Kranzler H.R.
        • Poling J.
        • et al.
        Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations.
        Arch Gen Psychiatry. 2009; 66: 1201-1209
        • Schrohl A.S.
        • Wurtz S.
        • Kohn E.
        • et al.
        Banking of biological fluids for studies of disease-associated protein biomarkers.
        Mol Cell Proteomics. 2009; 7: 2061-2066
        • Teunissen C.E.
        • Petzold A.
        • Bennett J.L.
        • et al.
        A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.
        Neurology. 2009; 73: 1914-1922
      1. National Cancer Institute best practices guidelines for biospecimen resources.
        (Prepared by the National Cancer Institute, National Institute of Health, and U.S. Department of Health and Human Services. June 2007. NIH pub no. 07-6229A) National Institutes of Health, Washington (DC)2007
        • International Society for Biological and Environmental Repositories
        Best practices for repositories I: collection, storage, and retrieval of human biological materials for research.
        Cell Preserv Technol. 2005; 3: 5-48
        • Organization for Economic Co-Operation and Development
        OECD best practice guidelines for biological resource centres.
        OECD Publishing, 2007 (Accessed February 1, 2009)
        • Eiseman E.
        • Bloom G.
        • Brower J.
        Case studies of existing human tissue repositories: “best practices” for a biospecimen resource for the genomic and proteomic era.
        RAND Corp, Santa Monica2003
        • Vanderstichele H.
        • Van Kerschaver E.
        • Hesse C.
        • et al.
        Standardization of measurement of beta-amyloid (1-42) in cerebrospinal fluid and plasma.
        Amyloid. 2007; 7: 245-258
        • Goossens W.
        • Van Duppen V.
        • Verwilghen R.L.
        K2- or K3-EDTA: the anticoagulant of choice in routine haematology?.
        Clin Lab Haematol. 1991; 13: 291-295
        • Shore P.M.
        • Thomas N.J.
        • Clark R.S.B.
        • et al.
        Continuous versus intermittent cerebrospinal fluid drainage after severe traumatic brain injury in children: effect on biochemical markers.
        J Neurotrauma. 2004; 21: 1113-1122
        • Maurer M.H.
        Proteomics of brain extracellular fluid (ECF) and cerebrospinal fluid (CSF).
        Mass Spectrom Rev. 2010; 29: 17-28
        • Zhang J.
        Proteomics of human cerebrospinal fluid—the good, the bad, and the ugly.
        Proteomics Clin Appl. 2007; 1: 805-819
        • Bergquist J.
        • Palmblad M.
        • Wetterhall M.
        • Hakanssaon P.
        • Markides K.E.
        Peptide mapping of proteins in human body fluids using electrospray ionization fourier transform ion cyclotron resonance mass spectrometry.
        Mass Spectrom Rev. 2002; 21: 2-15
        • Pineda J.A.
        • Lewis S.B.
        • Valadka A.B.
        • et al.
        Clinical significance of αII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury.
        J Neurotrauma. 2007; 24: 254-266
        • Huhmer A.F.
        • Biringer R.G.
        • Amato H.
        • Fonteh A.N.
        • Harrington M.G.
        Protein analysis in human cerebrospinal fluid: physiological aspects, current progress and future challenges.
        Dis Markers. 2006; 22: 3-26
        • Blennow K.
        • Fredman P.
        • Wallin A.
        • Gottfries C.G.
        • Langstrom G.
        • Svennerholm L.
        Protein analyses in cerebrospinal fluid.
        Eur Neurol. 1993; 33: 126-128
        • Hesse C.
        • Larsson H.
        • Fredman P.
        • et al.
        Measurement of apolipoprotein E (apoE) in cerebrospinal fluid.
        Neurochem Res. 2000; 25: 511-517
        • Wagner A.K.
        • Ren D.
        • Conley Y.P.
        • et al.
        Sex and genetic associations with cerebrospinal fluid dopamine and metabolite production after severe traumatic brain injury.
        J Neurosurg. 2007; 106: 538-547
        • Carrette O.
        • Burkhard P.R.
        • Hughes S.
        • Hochstrasser D.F.
        • Sanchez J.C.
        Truncated cystatin C in cerebrospinal fluid: technical [corrected] artifact or biological process?.
        Proteomics. 2005; 5: 3060-3065
        • Shores K.S.
        • Knapp D.R.
        Assessment approach for evaluating high abundance protein depletion methods for cerebrospinal fluid (CSF) proteomic analysis.
        J Proteome Res. 2007; 6: 3739-3751